Fierce Pharma
SEPTEMBER 12, 2024
Gilead Sciences is no stranger to making history in HIV. | In a study of more than 3,000 participants, Gilead's twice-yearly lenacapavir delivered a 96% reduction in HIV infections compared with background HIV incidence.
MedCity News
SEPTEMBER 12, 2024
While AI continues to advance, the healthcare industry requires a level of accuracy, understanding, and confidentiality that only well-trained human transcriptionists can consistently provide. The post The Human Touch: Why Human Transcriptionists Still Outperform AI in Healthcare appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
SEPTEMBER 12, 2024
Incyte’s late PD-1 entrant Zynyz has chalked up a unique clinical win. | Incyte’s late PD-1 entrant Zynyz has chalked up a unique clinical win. Yet company CEO Hervé Hoppenot views the antibody molecule not necessarily as a major revenue driver but as an aide to the company’s oncology pipeline.
MedCity News
SEPTEMBER 12, 2024
Sanofi is licensing a RadioMedix radiopharmaceutical in development for neuroendocrine tumors. The French pharmaceutical giant is responsible for global commercialization of the therapy, a potential competitor to the Novartis radiopharmaceutical Lutathera. The post Sanofi Jumps Into Radiopharmaceuticals, Paying €100M for Therapy That Could Rival a Novartis Drug appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
SEPTEMBER 12, 2024
By Dr. L. Alison McInnes and Jimmy Qian | We’re finally moving towards a causality-based nosology for psychiatry: specific symptoms with defined biological underpinnings can now be targeted by new therapies. But how do we bridge clinical development with real-world care? How do we ensure trial endpoints are synchronized with real-world measures, payer requirements, and clinical society guidelines?
MedCity News
SEPTEMBER 12, 2024
A private equity firm announced the merger of three assets that can reduce payers’s headaches when it comes to making sure that provider-submitted claims are accurate. In turn providers can get paid quickly. The post New Entity Aims to Help Payers Improve Payment Integrity appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
SEPTEMBER 12, 2024
This starts with viewing specialties such as oral health, maternal health, endocrinology, and cardiology — among others — as interconnected practices, not as separate areas. It also requires combining education, innovation, and investment to truly see — and feel — positive change and interconnected care The post Our Next Generations’ Health Depends on the Oral Health of Moms appeared first on MedCity News.
Fierce Pharma
SEPTEMBER 12, 2024
As mpox continues to cause illness and claim lives in Africa, Bavarian Nordic is retooling certain vaccine supply pacts to ensure its vaccine goes to the regions that need it most. | Facing high demand, Bavarian Nordic is retooling certain supply pacts to ensure its mpox shot Jynneos goes to the regions that need it most. It's also looking at partnerships to dramatically boost supply.
pharmaphorum
SEPTEMBER 12, 2024
Keir Starmer has promised the biggest 'reimagining' of the NHS in its history but said there will be no more funding without sweeping reforms
Fierce Pharma
SEPTEMBER 12, 2024
Akeso and Summit Therapeutics' ivonescimab showed strong efficacy against Merck's Keytruda in a phase 3 trial in China. The BIOSECURE Act sailed through a full House vote despite some objections. | Akeso and Summit Therapeutics' ivonescimab showed strong efficacy against Merck's Keytruda in a phase 3 trial in China. The BIOSECURE Act sailed through a full House vote despite some objections.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
MedCity News
SEPTEMBER 12, 2024
New research was published this week analyzing how AI can be used to better manage medications for senior patients who use multiple medications simultaneously. It analyzed FeelBetter’s AI platform, which pinpoints patients at high risk of deterioration and preventable hospitalization due to suboptimal medication management. The post AI Can Help Better Manage Polypharmacy Patients, Study Shows appeared first on MedCity News.
European Pharmaceutical Review
SEPTEMBER 12, 2024
Eli Lilly and Company is planning to invest a total of $1.8 billion in two manufacturing sites in Ireland , boosting its medicine production worldwide. Edgardo Hernandez , Executive Vice President and President of Lilly Manufacturing Operations, explained that the company ’s new investments will enhance production of medicines for diabetes, obesity and Alzheimer’s.
Pharmaceutical Commerce
SEPTEMBER 12, 2024
Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.
Referral MD
SEPTEMBER 12, 2024
The U.S. healthcare system faces several key challenges that significantly affect providers and patients, making it harder to deliver high-quality care while managing costs. Rising healthcare expenses strain providers and complicate patient access to affordable treatments. Simultaneously, the patient experience is becoming a major focus as healthcare organizations strive to meet the growing expectations of consumer-driven care.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
pharmaphorum
SEPTEMBER 12, 2024
Explore the ins and outs of Medicare drug pricing negotiations with Alice Valder Curran on this insightful podcast. Learn more about what comes next in this crucial healthcare sector.
Pharmaceutical Technology
SEPTEMBER 12, 2024
The data from two Phase III trials demonstrated GLP-1/glucagon agonist’s efficacy in reducing blood glucose and weight.
PharmaTimes
SEPTEMBER 12, 2024
New study highlights potential benefits of menopausal hormone therapy
Copyright Clearance Center
SEPTEMBER 12, 2024
September 12, 2024 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, will host the Town Hall event “AI & Copyright: Essential Information for Global, Cross-Border Business” via LinkedIn Live on Tuesday, 24 September, 10:00 am EST/4:00 pm CET. A panel of legal experts, including Prof. Daniel Gervais , Vanderbilt University Law School; Eleonora Rosati , Stockholm University; Karyn Temple , Motion Picture Association; and Atsushi Okada ,
PharmaTimes
SEPTEMBER 12, 2024
Promising results for novel orexin agonist in sleep-deprived volunteers
pharmaphorum
SEPTEMBER 12, 2024
Sanofi and Regeneron's Dupixent is effective in two skin disorders, bullous pemphigoid and chronic spontaneous urticaria
Healthcare Success
SEPTEMBER 12, 2024
Search technology has evolved drastically in recent years. “Stop talking about keywords, start talking about queries,” I said in a meeting. What started as simple keyword matching has transformed into a complex, AI-driven system, significantly impacting how we approach digital marketing and SEO. In this two-part series, I explore the evolution of organic and paid search, discuss its impact on your SEO strategy, and share how your healthcare organization can navigate these changes to enhance onli
PharmaVoice
SEPTEMBER 12, 2024
Eli Lilly’s head of ESG is maintaining a focus on sustainability even as the company’s expansion plans in weight loss drive a larger footprint and more social scrutiny.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
pharmaphorum
SEPTEMBER 12, 2024
GSK drops clinical-stage HSV vaccine after a disappointing phase 1/2 trial in genital herpes, leaving rivals Moderna and BioNTech out in front.
Pharmacy Times
SEPTEMBER 12, 2024
Parents of children with cancer had the highest risk of developing mental illness and cardiovascular diseases.
Pharmaceutical Commerce
SEPTEMBER 12, 2024
A cross-sectional study investigates changes in Medicare Advantage enrollment among Medicare beneficiaries with end-stage renal disease in the first two years of the Act.
Pharmacy Times
SEPTEMBER 12, 2024
Guselkumab (Tremfya; Johnson & Johnson) is the first and only approved fully human and dual-acting monoclonal antibody blocking interleukin-23 and binding to CD64 receptors.
PharmExec
SEPTEMBER 12, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmacy Times
SEPTEMBER 12, 2024
An overview of the potential treatment strategies for patients were presented at the 2024 World Conference on Lung Cancer.
PharmaTech
SEPTEMBER 12, 2024
Seventeen biologics and nine tides—five peptides and four oligonucleotides—were approved in 2023 alone, with further growth predicted.
Pharmacy Times
SEPTEMBER 12, 2024
Investigators obtained real-world evidence to evaluate the clinical outcomes of non-medical switching from the infliximab (Remicade; Janssen Immunology) to a biosimilar.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
331 
Let's personalize your content